We did not observe any significant changes in the IDH mutant Codel and IDH-wild-type glioma subtypes in terms of their epigenomic profile toward recurrent disease (Figures S1A and S1B; Table S1). The gene discussed is IDH2; the disease is central nervous system cancer.